Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
1.710
-0.190 (-10.01%)
At close: Dec 16, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $2.75 million as of December 24, 2025. Its market cap has decreased by -89.88% in one year.
Market Cap
2.75M
Enterprise Value
5.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.71
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 2.75M, a decrease of -95.90%. That is a compound annual growth rate of -46.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | 43.76M | -34.67% |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 359.24M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |